Optimal High-Dose-Rate Brachytherapy Fractionation Scheme After Keloid Excision: A Retrospective Multicenter Comparison of Recurrence Rates and Complications

Eveline Bijlard*, Gerda M. Verduijn, J. X. Harmeling, Homan Dehnad, Frank B. Niessen, Otto W.M. Meijer, Marc A.M. Mureau

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Purpose: To determine the optimal brachytherapy dose and fractionation scheme for keloid treatment. Methods and Materials: Patient cohorts from 3 centers treated with keloid excision followed by 2 × 9 Gy, 3 × 6 Gy, or 2 × 6 Gy high-dose-rate brachytherapy were retrospectively compared regarding recurrence (after at least 12 months' follow-up) and complications (after at least 1 month's follow-up), using logistic regression analyses. Results: A total of 238 keloids were treated. An overall full recurrence rate of 8.3% was found. After correction for confounders (sex, skin color, keloid location, keloid duration) no statistically significant differences in recurrence rates could be discerned between fractionation schemes. There were 12.8% major and 45.6% minor complication rates. Lower radiation dose resulted in significantly fewer complications (odds ratio 0.35, P=.015). Conclusions: After excision of resistant keloids, high-dose-rate brachytherapy with a biological equivalent dose of approximately 20 Gy is recommended, on the basis of low recurrence and complication rates.

Original languageEnglish
Pages (from-to)679-686
Number of pages8
JournalInternational Journal of Radiation Oncology Biology Physics
Volume100
Issue number3
DOIs
Publication statusPublished - 1 Mar 2018

Cite this